BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Familial Chylomicronemia Syndrome readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Familial Chylomicrone
 mia Syndrome\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05185843-1044@assetmemo.bio
DTSTAMP:20261121T010013Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Tryngolza (Olezarsen): Phase 3 readout est. (NCT05185843)
DESCRIPTION:Tryngolza (Olezarsen)\, phase 3\, Familial Chylomicronemia Synd
 rome.\nStudy: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) A
 dministered to Adults With Familial Chylomicronemia Syndrome (FCS) Previou
 sly Treated With Volanesorsen\nEstimated primary completion: June 2027. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/olezarsen#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT05185843
URL:https://assetmemo.bio/drug/olezarsen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05130450-1044@assetmemo.bio
DTSTAMP:20261121T010013Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:Tryngolza (Olezarsen): Phase 3 readout est. (NCT05130450)
DESCRIPTION:Tryngolza (Olezarsen)\, phase 3\, Familial Chylomicronemia Synd
 rome.\nStudy: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) i
 n Participants With Familial Chylomicronemia Syndrome (FCS)\nEstimated pri
 mary completion: February 2028. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/olezarsen#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT05130450
URL:https://assetmemo.bio/drug/olezarsen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07727538-1044@assetmemo.bio
DTSTAMP:20261121T010013Z
DTSTART;VALUE=DATE:20300831
DTEND;VALUE=DATE:20300901
SUMMARY:Tryngolza (Olezarsen): Phase 3 readout est. (NCT07727538)
DESCRIPTION:Tryngolza (Olezarsen)\, phase 3\, Familial Chylomicronemia Synd
 rome.\nStudy: A Study of Olezarsen for the Treatment of Familial Chylomicr
 onemia Syndrome (FCS) in Pediatric Participants\nEstimated primary complet
 ion: August 2030. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ole
 zarsen#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07727538
URL:https://assetmemo.bio/drug/olezarsen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
